Food Allergy

The House Appropriations Committee adopted an amendment that would require the inclusion of peanut-containing products into the Special Supplemental Nutrition Program for Women, Infants, and Children.

A recent study found that health care professionals were increasingly able to identify infants and young children with anaphylaxis by following modified criteria.

Giving young children an epinephrine autoinjection can be a positive and confidence-boosting experience for families, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

In February, the FDA approved omalizumab for the reduction of food allergic reactions. First approved in 2003 for allergic asthma, this anti-IgE monoclonal antibody developed by Genentech and Novartis inhibits the allergic reaction process.

The risk of developing alopecia areata increases when both seasonal and food allergies are present, according to a study published in The European Journal of Allergy and Clinical Immunology.

A crossover study revealed that dry powder epinephrine administered via nasal spray yielded drug exposures equal to or higher than those provided by autoinjectors in a canine model.

Significant disparities exist between patients with peanut allergies who are currently receiving oral immunotherapy and those who are not, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Families of children with peanut allergies that pursued oral immunotherapy cited remission and the potential for disease modification as their reason, according to a study published in The Journal of Allergy and Immunology: In Practice.

CHICAGO — Most individuals with cancer who used an AI-based nutritional platform reported the application helped them regulate their diets and improved their quality of life, according to study results presented at ASCO Annual Meeting.

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended marketing authorization of ARS Pharmaceuticals’ EURneffy epinephrine nasal spray in the European Union, according to a press release.